Dr Seerapani Gopaluni-Nephrologist

Dr Seerapani Gopaluni, Nephrologist

MBBS, MRCP, CCT

About : Dr Seerapani Gopaluni, Nephrologist

Dr. Seerapani Gopaluni is a highly respected and renowned Nephrologist with over 20 years of experience in Hyderabad. He completed his Bachelor of Medicine and Bachelor of Surgery (MBBS) from Dr. Y.S.R University of Health Sciences in Vijayawada, Andhra Pradesh. Dr. Seerapani received his Membership of the Royal Colleges of Physicians (MRCP) and earned the Certificate of Completion of Training (CCT) in Nephrology from the British Council in the United Kingdom. He also underwent Internal Medical Training at the prestigious Oxford University Clinical Academic Graduate School in the United Kingdom. Dr. Seerapani holds a Doctor of Philosophy (PhD) in Renal Medicine from the University of Cambridge in the United Kingdom. 

Dr. Seerapani specializes in treating various kidney disorders, including chronic kidney disease and acute kidney failure management. He is an expert in renal health, dealing with Glomerulonephritis, Polycystic kidney disease, Kidney stones, and Nephrotic syndrome. Dr. Seerapani's specialization extends into expertise in renal transplantation and managing autoimmune conditions such as lupus and vasculitis. 

He has received numerous notable accolades in Nephrology throughout Europe. Moreover, he has published over two dozen seminal research papers in renowned journals. You can book an appointment with Dr. Seerapani Gopaluni, who currently works as a Consultant Nephrologist at Citizens Specialty Hospitals - Nallagandla.

Specializations

  • Nephrologist/ Renal Specialist

Qualifications

  • MBBS - Dr. NTR University of Health Sciences - 2003 - Andhra Pradesh verified-badgeVerified
  • Training - General Internal Medicine - Oxford University - 2014 Verified
  • MRCP Nephro - 2008 - UK Verified
  • CCT - Nephrology - 2013 - UK Verified
  • PhD - Cambridge University Verified
  • Training - Nephrology - Oxford University - 2014 Verified

Experiences

  • Consultant Nephrologist Citizens Specialty Hospitals - Nallagandla - Currently Working

Registrations

  • 49196 Andhra Pradesh Medical Council 2003 verified-badgeVerified

Awards and Recognitions

  • First Division in MBBS Final Examinations
  • Distinction in Ophthalmology University Examination
  • Gold Medal in ENT University Examination
  • Distinction in Anatomy University Examination
  • Distinction Poster at ATC Boston May 2009
  • Teacher of the Month for Teaching Medical Students at John Radcliffe Hospitals, Oxford May 2012

Paper Presentations

  • European Vasculitis Society Meeting Early Disease Response as Predictors of Long Term Outcomes in ANCA Associated Vasculitis - 2017
  • ALEmtuzumab for Relapsing and Refractory Primary Systemic Vasculitis – A Trial of Efficacy and Safety (ALEVIATE): A Randomised Open Label Phase II Clinical Trial, Vasculitis conference, Philadelphia, 2019
  • Peripheral T helper cells may play a role in the pathogenesis of ANCA associated vasculitis, Renal Association Oct 14th, 2020
  • Wagner J , Harrison E. M , Martinez M , Pero D , Blane B , Mayer G , Leierer J , Gopaluni S , Holmes M A , Parkhill J , Peacock S J , Jayne D R , Kronbichler A ( 2019 ). The Composition and Functional Protein Subsystems of The Human Nasal Microbiome in Granulomatosis with Polyangiitis ? : A Pilot Study. Microbiome ( 2019 ) 7 : 137 https://doi.org/10.1186/s40168-019-0753-z
  • Evaluation of PR3 - ANCA Status After Rituximab for ANCA -Associated Vasculitis. McClure ME , Wason J , Gopaluni S , Tieu J , Smith RM , Jayne DR , Jones RB. J Clin Rheumatol. 2019 Mar 20. doi: 10.1097/RHU.0000000000001030
  • A Novel Glucocorticoid - Free Maintenance Regimen for Anti-Neutrophil Cytoplasm Antibody - Associated Vasculitis. Pepper RJ , McAdoo SP , Moran SM , Kelly D , Scott J , Hamour S , Burns A , Griffith M , Galliford J , Levy JB , Cairns TD , Gopaluni S , Jones RB , Jayne D , Little MA , Pusey CD , Salama AD. Rheumatology ( Oxford ). 2019 Feb 1 ; 58 ( 2 ) : 260 - 268. doi: 10.1093/rheumatology/key288.
  • Effect of Disease Activity at Three and Six Months After Diagnosis on Long - Term Outcomes in Antineutrophil Cytoplasmic Antibody - Associated Vasculitis. Gopaluni S , Flossmann O , Little MA , O’Hara P , Bekker P , Jayne D ; European Vasculitis Society. Arthritis Rheumatol. 2019 May ; 71 ( 5 ) : 784 - 791. doi: 10.1002/art.40776. Epub 2019 Mar 28.
  • B Cell Therapy in ANCA - Associated Vasculitis : Current and Emerging Treatment Options. McClure M , Gopaluni S , Jayne D , Jones R. Nat Rev Rheumatol. 2018 Oct ; 14 ( 10 ) : 580 - 591. doi: 10.1038/s41584-018-0065-x. Epub 2018 Aug 14. Review.
  • A Retrospective Study Comparing The Phenotype and Outcomes of Patients with Polyarteritis Nodosa between UK and Turkish Cohorts. Karadag O , Erden A , Bilginer Y , Gopaluni S , Sari A , Armagan B , Ertenli I , Ozen S , Jayne D. Rheumatol Int. 2018 Oct ; 38 ( 10 ) : 1833 - 1840. doi: 10.1007/s00296-018-4122-1. Epub 2018 Aug 11.
  • Trimethoprim - Sulfamethoxazole Prophylaxis Prevents Severe / Life - Threatening Infections following Rituximab in Antineutrophil Cytoplasm Antibody - Associated Vasculitis. Kronbichler A , Kerschbaum J , Gopaluni S , Tieu J , Alberici F , Jones RB , Smith RM , Jayne DRW. Ann Rheum Dis. 2018 Oct ; 77 ( 10 ) : 1440 - 1447. doi: 10.1136/annrheumdis2017-212861. Epub 2018 Jun 27.
  • McAdoo , S. P. , Medjeral - Thomas , N. , Gopaluni , S. , Tanna , A. , Mansfield , N. , Galliford , J. , Griffith , M. , et al. ( 2018 ). Long - Term Follow - Up of A Combined Rituximab and Cyclophosphamide Regimen in Renal Anti - Neutrophil Cytoplasm Antibody - Associated Vasculitis. Nephrology , Dialysis , Transplantation : Official Publication of The European Dialysis and Transplant Association – European Renal Association , 2018 , 33 ( 5 ) , 899. https://doi.org/10.1093/ndt/gfy075
  • Gopaluni , S. , Smith , R. M. , Lewin , M. , McAlear , C. A. , Mynard , K. , Jones , R. B. , Jayne , D. R. W. ( 2017 ). Rituximab Versus Azathioprine as Therapy for Maintenance of Remission for Anti - Neutrophil Cytoplasm Antibody -Associated Vasculitis ( RITAZAREM ) : Study Protocol for a Randomized Controlled Trial. Trials , 18 ( 1 ) , 112. http://doi.org/10.1186/s13063-017-1857-z
  • Gopaluni , S. , Sherif , M. , & Ahmadouk , N. A. 2016. Cochrane Systematic Review : Interventions for Chronic Kidney Disease - Associated Restless Legs Syndrome. Cochrane Database of Systematic Reviews. doi: 10.1002/ 14651858. CD010690.pub2
  • Gopaluni , S. , & Jayne , D. ( 2016 ). Clinical Trials in Vasculitis. Current Treatment Options in Rheumatology , 2(2) , 161–177. doi:10.1007/s40674-016-0045-8
  • Gopaluni , S. and Jayne , D. 2015. Immune Vasculitis. eLS. 1– 8. DOI: 10.1002/9780470015902.a0002150.pub3
  • Hindocha , S. , Gopaluni , S. , Collins , G. P. , & Shenbagaraman , P. ( 2015 ). Focal Segmental Glomerulosclerosis in A Patient with Mantle Cell Lymphoma. BMJ Case Reports , 2015. doi:10.1136/bcr-2015-211765
  • Gopaluni , S. , Gibson , M. , & Mohteshamzadeh , M. ( 2014 ). An Unusual Case of Familial Cystic Kidney Disease. Clinical Kidney Journal , 7 ( 5 ) , 484 – 485. doi:10.1093/ckj/sfu075
  • Gopaluni , S. , Sherif , M. , & Ahmadouk , N. A. ( 2013 ). Protocol - Interventions for Chronic Kidney Disease -Associated Restless Legs Syndrome. Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD010690.
  • Ball MJ , Gopaluni S , Mathavakkannan S , Brian M , and Farrington K. An Immunocompromised Dialysis Patient with Skin and Bone Lesions. NDT Plus 2010 0: sfq010v1-sfq010; doi:10.1093/ndtplus/sfq010
  • S Gopaluni , S Lines , AJP Lewington , Acute Kidney Injury in The Critically ill Patient , Current Anaesthesia & Critical Care 21 ( 2 ) , 60 - 64 , April 2010
  • Seerapani Gopaluni , Aadil Shaukat , Martin Gray , Roshni Gokhale and M Al - Bustami Premature Myocardial Infarction Presenting with Acuacutete Pulmonary Embolism : A Case Report. Journal of Medical Case Reports 2009 , 3 : 8786

Report an error

Dr Seerapani Gopaluni Practice Locations

location-icon

1-100/1/CCH

Near Aparna Sarovar, Nallagandla

Nallagandla, Hyderabad

Get directions

time-icon

OP Timings

Mon - Sat

12:00 noon - 04:00 pm
...

Fee : 800

Write a review for Dr Seerapani Gopaluni

Which clinic or hospital you visited

empty

I Recommend this Doctor for

How was your experience

Write your experience aboutDr Seerapani Gopaluni

skedoc | Right Doctor Right Advice

skedoc brings you healthcare that is relevant to your specific health needs. We make finding the Right Doctor and the Right Advice extremely easy.

  • Home
  • Search
  • Doctors
  • Hospitals